General
Preferred name
trans-Urocanic Acid
Synonyms
4-Imidazoleacrylic acid ()
trans-UCA ()
(E)-Urocanic acid ()
Urocanic-acid Hydrochloride ()
cis-urocanic acid, emulsion, BioCis ()
Urocanic acid ()
P&D ID
PD002631
CAS
7699-35-6
6159-48-4
104-98-3
3465-72-3
Tags
available
drug candidate
Drug Status
experimental
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Urocanic acid, produced in the upper layers of mammalian skin, is a major absorber of ultraviolet radiation (UVR).
DESCRIPTION trans-urocanic acid (trans-UCA), a natural epidermal constituent, inhibits human natural killer cell (NK) activity in vitro. trans-urocanic acid is active in regulating an immune function[1].
PRICE 29
DESCRIPTION Histidine ammonia-lyase and decarboxylase inhibitor (LOPAC library)
DESCRIPTION Urocanic acid (4-Imidazoleacrylic acid), synthesized in the epidermis, functions as a primary absorber of ultraviolet (UV) radiation in mammalian skin. (TargetMol Bioactive Compound Library)
DESCRIPTION trans-Urocanic Acid ((E)-Urocanic acid), a compound predominantly distributed in the hippocampus and prefrontal cortex, is an isomer of cis-UCA, an epidermal UV-protectant, which enhances the stability of tenofovir eplerenomide in long-acting HIV applications. trans-Urocanic acid potently modulates immune trans-urocanic acid effectively modulates immune function, inhibits human natural killer cell activity in vitro, and can be used in Alzheimer's disease research. (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
1
Compound Sets
8
Cayman Chemical Bioactives
DrugBank
Enamine BioReference Compounds
LOPAC library
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
43
Properties
(calculated by RDKit )
Molecular Weight
138.04
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
0.51
TPSA
65.98
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
5.0
QED
0.58
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
Histidine ammonia-lyase/ decarboxylase
Target
Endogenous Metabolite
HTR2A
Phase
Phase 2
MOA
serotonin receptor agonist
Pathway
Metabolic Enzyme/Protease
Metabolism
Source data